• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无静脉血栓栓塞危险因素患者中低剂量奥氮平所致急性肺栓塞

Acute Pulmonary Embolism Associated with Low-Dose Olanzapine in a Patient without Risk Factors for Venous Thromboembolism.

作者信息

Vu Vu Hoang, Khang Nguyen Duong, Thao Mai Thanh, Khoi Le Minh

机构信息

Cardiovascular Center, University Medical Center, University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam.

Department of Radiology, University Medical Center, Ho Chi Minh City, Vietnam.

出版信息

Case Rep Vasc Med. 2021 Jul 27;2021:5138509. doi: 10.1155/2021/5138509. eCollection 2021.

DOI:10.1155/2021/5138509
PMID:34354848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8331313/
Abstract

BACKGROUND

Olanzapine is a second-generation antipsychotic drug commonly prescribed for certain mental/mood conditions such as schizophrenia and bipolar disorders. This agent has been considered a precipitating factor for venous thromboembolism formation. Most of the cases previously reported were associated with high-dose olanzapine therapy or in patients with high-risk factors for the development of thromboembolism. . We report a patient who developed pulmonary embolism after a long course of low-dose olanzapine. A 66-year-old female patient suffering from insomnia had been prescribed olanzapine 2.5 mg and paroxetine 10 mg for two years. The patient suddenly developed a syncopal episode at home and was immediately brought to the hospital. The diagnosis of pulmonary embolism was made by chance during the computerized tomography of coronary arteries. The patient made a full recovery under conventional treatment and was discharged in stable condition. The thoracic computed tomography taken two months after discharge showed a completely normal pulmonary arterial tree.

CONCLUSION

Olanzapine-associated pulmonary embolism is a rare entity and might be missed if the physician in charge is not vigilant and well informed. Even low-dose olanzapine can be associated with pulmonary embolism in patients with low classic risk factors if the treatment is prolonged. Pulmonary embolism should be sought in patients taking olanzapine even though the presenting manifestations are nonspecific.

摘要

背景

奥氮平是一种第二代抗精神病药物,常用于治疗某些精神/情绪疾病,如精神分裂症和双相情感障碍。该药物被认为是静脉血栓栓塞形成的一个促发因素。先前报道的大多数病例与高剂量奥氮平治疗有关,或发生在有血栓栓塞发生高危因素的患者中。我们报告一例在长期服用低剂量奥氮平后发生肺栓塞的患者。一名66岁患有失眠症的女性患者服用奥氮平2.5毫克和帕罗西汀10毫克已有两年。患者在家中突然发生晕厥,随后立即被送往医院。在冠状动脉计算机断层扫描过程中偶然诊断出肺栓塞。患者在接受常规治疗后完全康复,出院时病情稳定。出院两个月后进行的胸部计算机断层扫描显示肺动脉树完全正常。

结论

奥氮平相关的肺栓塞是一种罕见情况,如果主管医生不警惕且了解不足,可能会漏诊。如果治疗时间延长,即使是低剂量奥氮平也可能与低经典风险因素患者的肺栓塞有关。即使临床表现不具特异性,服用奥氮平的患者也应排查肺栓塞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c4/8331313/7cc55c2075a7/CRIVAM2021-5138509.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c4/8331313/5ceecb829250/CRIVAM2021-5138509.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c4/8331313/32ccb9644a40/CRIVAM2021-5138509.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c4/8331313/7cc55c2075a7/CRIVAM2021-5138509.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c4/8331313/5ceecb829250/CRIVAM2021-5138509.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c4/8331313/32ccb9644a40/CRIVAM2021-5138509.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b6c4/8331313/7cc55c2075a7/CRIVAM2021-5138509.003.jpg

相似文献

1
Acute Pulmonary Embolism Associated with Low-Dose Olanzapine in a Patient without Risk Factors for Venous Thromboembolism.无静脉血栓栓塞危险因素患者中低剂量奥氮平所致急性肺栓塞
Case Rep Vasc Med. 2021 Jul 27;2021:5138509. doi: 10.1155/2021/5138509. eCollection 2021.
2
Rare and Underestimated Association of Pulmonary Embolism and Olanzapine Therapy; Report of Two Cases.肺栓塞与奥氮平治疗的罕见且被低估的关联;两例报告
Arch Acad Emerg Med. 2021 Feb 5;9(1):e17. doi: 10.22037/aaem.v9i1.1063. eCollection 2021.
3
[Antipsychotics in bipolar disorders].[双相情感障碍中的抗精神病药物]
Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5.
4
Olanzapine and pulmonary embolism, a rare association: a case report.奥氮平与肺栓塞:一种罕见的关联——病例报告
Cases J. 2010 Jan 22;3:36. doi: 10.1186/1757-1626-3-36.
5
Olanzapine and venous thromboembolism.奥氮平与静脉血栓栓塞症
Int Clin Psychopharmacol. 2003 Sep;18(5):299-300. doi: 10.1097/01.yic.0000085241.99018.30.
6
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].[精神分裂症患者护理环境的成本效益分析:长效注射制剂下非典型抗精神病药物的影响]
Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5.
7
Venous Thromboembolism as an Adverse Effect During Treatment With Olanzapine: A Case Series.奥氮平治疗期间静脉血栓栓塞作为一种不良反应:病例系列
Front Psychiatry. 2019 May 15;10:330. doi: 10.3389/fpsyt.2019.00330. eCollection 2019.
8
Is there association of olanzapine and pulmonary embolism: A case report.奥氮平与肺栓塞有关联吗:一例病例报告。
Clin Case Rep. 2022 Jun 3;10(6):e05805. doi: 10.1002/ccr3.5805. eCollection 2022 Jun.
9
Venous thrombosis during olanzapine treatment: a complex association.奥氮平治疗期间的静脉血栓形成:一种复杂的关联。
Neth J Med. 2018 Aug;76(6):263-268.
10
Pulmonary embolism related to amisulpride treatment: a case report.与氨磺必利治疗相关的肺栓塞:一例报告
Case Rep Psychiatry. 2013;2013:718950. doi: 10.1155/2013/718950. Epub 2013 Feb 28.

引用本文的文献

1
An Exploratory Research to Evaluate the 30 Most Common Pulmonary Embolism Drugs in the Food and Drug Administration Adverse Event Reporting System.一项探索性研究,旨在评估美国食品药品监督管理局不良事件报告系统中30种最常见的肺栓塞药物。
Clin Respir J. 2025 Jun;19(6):e70054. doi: 10.1111/crj.70054.
2
Is there association of olanzapine and pulmonary embolism: A case report.奥氮平与肺栓塞有关联吗:一例病例报告。
Clin Case Rep. 2022 Jun 3;10(6):e05805. doi: 10.1002/ccr3.5805. eCollection 2022 Jun.

本文引用的文献

1
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).2019年欧洲心脏病学会(ESC)与欧洲呼吸学会(ERS)合作制定的急性肺栓塞诊断和管理指南。
Eur Heart J. 2020 Jan 21;41(4):543-603. doi: 10.1093/eurheartj/ehz405.
2
Antipsychotic drug exposure and risk of venous thromboembolism: a systematic review and meta-analysis of observational studies.抗精神病药物暴露与静脉血栓栓塞风险:观察性研究的系统评价和荟萃分析
Drug Saf. 2014 Feb;37(2):79-90. doi: 10.1007/s40264-013-0127-6.
3
Four cases of venous thromboembolism associated with olanzapine.
4例与奥氮平相关的静脉血栓栓塞病例。
Psychiatry Clin Neurosci. 2009 Feb;63(1):116-8. doi: 10.1111/j.1440-1819.2008.01899.x. Epub 2008 Dec 1.
4
Associations between venous thromboembolism and antipsychotics. A study of the WHO database of adverse drug reactions.静脉血栓栓塞与抗精神病药物之间的关联。一项关于世界卫生组织药物不良反应数据库的研究。
Drug Saf. 2008;31(8):685-94. doi: 10.2165/00002018-200831080-00005.
5
Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents.使用非典型和传统抗精神病药物治疗的老年患者中的静脉血栓栓塞症。
Arch Intern Med. 2005;165(22):2677-82. doi: 10.1001/archinte.165.22.2677.
6
Pulmonary embolism possibly associated with olanzapine treatment.肺栓塞可能与奥氮平治疗有关。
BMJ. 2003 Dec 13;327(7428):1384. doi: 10.1136/bmj.327.7428.1384.
7
Olanzapine and venous thromboembolism.奥氮平与静脉血栓栓塞症
Int Clin Psychopharmacol. 2003 Sep;18(5):299-300. doi: 10.1097/01.yic.0000085241.99018.30.